Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interleukin-12 in Advanced Cervical Cancer
NCT00003017Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Jul 1997
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant interleukin-12 in Cervical Cancer (CC), sponsored by Eastern Cooperative Oncology Group. Started Jul 1997; status: completed.
02
Drugs
recombinant interleukin-12
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00003017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003017.